-
1
Cicatricial ectropion and madarosis associated with panitumumab treatment of metastatic colorectal cancer
Published 2020-09-01Subjects: “…Anti-epidermal growth factor receptor (anti-EGFR)…”
Get full text
Article -
2
MET Receptor Amplification Drives Resistance to Anti-EGFR Therapies
Published 2019-06-01Subjects: “…anti-epidermal growth factor receptor…”
Get full text
Article -
3
Retrospective analysis to assess the feasibility of escalated dose of nimotuzumab in patients with locally advanced head and neck cancer
Published 2017-01-01Subjects: “…Anti-epidermal growth factor receptor…”
Get full text
Article -
4
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies
Published 2021-10-01Subjects: Get full text
Article -
5
A Rare BRAF Fusion in Advanced Rectal Cancer Treated with Anti-Epidermal Growth Factor Receptor Therapy
Published 2021-06-01Subjects: Get full text
Article -
6
Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metas...
Published 2024-02-01Subjects: “…Anti-epidermal growth factor receptor…”
Get full text
Article -
7
Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma
Published 2020-03-01Subjects: “…anti‐epidermal growth factor receptor…”
Get full text
Article -
8
Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer
Published 2021-02-01Subjects: Get full text
Article -
9
The efficacy and safety of anti-EGFR target agents in patients with potentially resectable metastatic colorectal cancer: a meta-analysis of randomized controlled trials
Published 2023-10-01Subjects: “…Anti-epidermal growth factor receptor (anti-EGFR) target agent…”
Get full text
Article -
10